Focused on transformative treatment technologies in dermatology and oncology.
The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet needs in the skincare market.
Annual Report and Accounts 2025
Half-year Report
Incanthera shares jump 21% after it acquires Swiss skincare brand and appoints new chief executive